Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Steven F, Powell"'
Autor:
Jonathan S. Bleeker, MD, Christopher J. Sumey, MD, Steven F. Powell, MD, Preston D. Steen, MD, Michael D. Keppen, MD, Michele Lohr, MD, Thavam Thambi-Pillai, MD, Peter Kurniali, MD, Miroslaw Mazurczak, MD, Mark M. Gitau, MD, Miran J. Blanchard, MD, Ryan K. Nowak, MD, Steven McGraw, MD, Robert Sticca, MD, Daniel Tuvin, MD, Gary Timmerman, MD
Publikováno v:
Surgery Open Science, Vol 2, Iss 4, Pp 25-31 (2020)
Background: Treatment paradigms for borderline resectable pancreatic cancer are evolving with increasing use of neoadjuvant chemotherapy and neoadjuvant chemoradiation. Variations in the definition of borderline resectable pancreatic cancer and neoad
Externí odkaz:
https://doaj.org/article/5d764d46775f4490a0e8ad7e217a1857
Autor:
Ezra E. W. Cohen, Michael J. Pishvaian, Dale R. Shepard, Ding Wang, Jared Weiss, Melissa L. Johnson, Christine H. Chung, Ying Chen, Bo Huang, Craig B. Davis, Francesca Toffalorio, Aron Thall, Steven F. Powell
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-11 (2019)
Abstract Background Expressed on activated T and natural killer cells, 4-1BB/CD137 is a costimulatory receptor that signals a series of events resulting in cytokine secretion and enhanced effector function. Targeting 4-1BB/CD137 with agonist antibodi
Externí odkaz:
https://doaj.org/article/e6f6835c562540da97a0a035be2449fc
Autor:
Juan L. Callejas-Valera, Daniel W. Vermeer, Christopher T. Lucido, Caitlin Williamson, Marisela Killian, Paola D. Vermeer, William C. Spanos, Steven F. Powell
Publikováno v:
Cancers, Vol 14, Iss 10, p 2499 (2022)
Background: Chemoradiotherapy is a standard treatment for HNSCC. Blockade of the PD-1/L1-2 interaction may represent a target to overcome immune escape during this treatment. Methods: Utilizing a HNSCC mEERL C57BL/6 mouse model, we evaluated a PD-1 b
Externí odkaz:
https://doaj.org/article/e6df8dd678774a7ead55f7d777e5acdb
Autor:
Marina C. Garassino, Shirish Gadgeel, Giovanna Speranza, Enriqueta Felip, Emilio Esteban, Manuel Dómine, Maximilian J. Hochmair, Steven F. Powell, Helge G. Bischoff, Nir Peled, Francesco Grossi, Ross R. Jennens, Martin Reck, Rina Hui, Edward B. Garon, Takayasu Kurata, Jhanelle E. Gray, Paul Schwarzenberger, Erin Jensen, M. Catherine Pietanza, Delvys Rodríguez-Abreu
Publikováno v:
Scientia
Pembrolizumab; Non-small-cell lung cancer Pembrolizumab; Cáncer de pulmón de células no pequeñas Pembrolizumab; Càncer de pulmó de cèl·lules no petites Clinical trials frequently include multiple end points that mature at different times. The
Publikováno v:
Cancers, Vol 13, Iss 20, p 5206 (2021)
Head and neck squamous cell carcinoma (HNSCC) is a unique malignancy associated with two distinct risk factors: exposure to typical carcinogens and infection of human papillomavirus (HPV). HPV encodes the potent oncoproteins E6 and E7, which bypass m
Externí odkaz:
https://doaj.org/article/9e3e7664a0394784849c3f1d82d7ada7
Autor:
Steven F Powell, Miroslaw Mazurczak, Elie G Dib, Jonathon S Bleeker, Louis H Geeraerts, Matthew Tinguely, Michele M Lohr, Steven C McGraw, Ashley W Jensen, Christie A Ellison, Lora J Black, Susan E Puumala, Valerie J Reed, W Keith Miskimins, John H Lee, William C Spanos
Background: Chemoradiotherapy (CRT) for locally-advanced head and neck squamous cell carcinoma (LA-HSNCC) yields 5-year survival rates near 50% despite causing significant toxicity. Dichloroacetate (DCA), a pyruvate dehydrogenase kinase metabolic inh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8124c6a9237b6b377544ef5f5a280766
https://doi.org/10.21203/rs.3.rs-1132811/v1
https://doi.org/10.21203/rs.3.rs-1132811/v1
Autor:
Steven F. Powell, Miroslaw Mazurczak, Elie G. Dib, Jonathon S. Bleeker, Louis H. Geeraerts, Matthew Tinguely, Michele M. Lohr, Steven C. McGraw, Ashley W. Jensen, Christie A. Ellison, Lora J. Black, Susan E. Puumala, Valerie J. Reed, W. Keith Miskimins, John H. Lee, William C. Spanos
Publikováno v:
Invest New Drugs
Chemoradiotherapy (CRT) for locally-advanced head and neck squamous cell carcinoma (LA-HSNCC) yields 5-year survival rates near 50% despite causing significant toxicity. Dichloroacetate (DCA), a pyruvate dehydrogenase kinase metabolic inhibitor, redu
Autor:
Steven F Powell, Arkadiusz Z Dudek
Publikováno v:
Pharmacogenomics and Personalized Medicine, Vol 2009, Iss default, Pp 21-37 (2009)
Steven F Powell1, Arkadiusz Z Dudek21Department of Medicine, University of Minnesota, Minneapolis, MN, USA; 2Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN, USAAbstract: Pemetrexed (ALIMTA, LY231514, MT
Externí odkaz:
https://doaj.org/article/962cf97ae2e64883a68741f450dbea27
Publikováno v:
Oncology (Williston Park, N.Y.). 32(10)
Autor:
Jacqueline M. Lafky, Rui Qin, Charles L. Loprinzi, Kathryn J. Ruddy, Leah L. Dietrich, Rudolph M. Navari, Steven F. Powell, Heshan Liu, David D. Biggs, Madhuri Bajaj
We examined the efficacy of olanzapine for the prevention of nausea and vomiting in patients receiving highly emetogenic chemotherapy.In a randomized, double-blind, phase 3 trial, we compared olanzapine with placebo, in combination with dexamethasone
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::066f76f6baa16c5a005b2904d5680a82
https://europepmc.org/articles/PMC5344450/
https://europepmc.org/articles/PMC5344450/